Ospemifene in the treatment of vulvovaginal atrophy.

Barnes, Kylie N; Pearce, Erica F; Yancey, Abigail M; Forinash, Alicia B

Barnes, Kylie N; Pearce, Erica F; Yancey, Abigail M; Forinash, Alicia B.

Affiliation

Barnes KN; University of Missouri Kansas City School of Pharmacy, Kansas City, MO, USA.

Ann Pharmacother ; 48(6): 752-7, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24615631

Subject(s)

Dyspareunia/drug therapy; Selective Estrogen Receptor Modulators/therapeutic use; Tamoxifen/analogs & derivatives; Vagina/pathology; Vulva/pathology; Atrophy/drug therapy; Female; Humans; Selective Estrogen Receptor Modulators/adverse effects; Selective Estrogen Receptor Modulators/pharmacology; Tamoxifen/adverse effects; Tamoxifen/pharmacology; Tamoxifen/therapeutic use

Key words

dyspareunia; ospemifene; vaginal atrophy; vulvovaginal atrophy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Vagina / Vulva / Selective Estrogen Receptor Modulators / Dyspareunia Type of study: Clinical_trials / Systematic_reviews Limits: Female / Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google